I believe most of the shareholders here wish that ANP will follow Sarepta's SP step. They sure have potential in their pipeline. Time will tell when they're going to provide the next piece on the rare disease puzzle.
I enjoy your all your posting itsa. Keep them coming mate.
Have a great week ahead to you all.
- Forums
- ASX - By Stock
- Ann: Positive feedback received on Paediatric Investigation Plan
I believe most of the shareholders here wish that ANP will...
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.9¢ |
Change
-0.001(1.25%) |
Mkt cap ! $83.73M |
Open | High | Low | Value | Volume |
8.1¢ | 8.2¢ | 7.9¢ | $153.8K | 1.914M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 927041 | 7.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.1¢ | 218878 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 927041 | 0.079 |
7 | 479515 | 0.078 |
5 | 777652 | 0.077 |
4 | 296000 | 0.076 |
8 | 892416 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.081 | 218878 | 1 |
0.082 | 183268 | 1 |
0.083 | 37500 | 1 |
0.086 | 96543 | 1 |
0.089 | 300000 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online